Cargando…
Burkitt Lymphoma: beyond discoveries
First described in 1958 in Uganda, Burkitt lymphoma (BL) attracted interest worldwide following reports of its uneven geographic distribution and rapidly fatal clinical course. Both suggested infectious etiology and curability. Seminal discoveries followed in quick succession. Viral etiology – due t...
Autor principal: | Mbulaiteye, Sam M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852287/ https://www.ncbi.nlm.nih.gov/pubmed/24079372 http://dx.doi.org/10.1186/1750-9378-8-35 |
Ejemplares similares
-
The next step for Burkitt lymphoma
por: Cho, Bin
Publicado: (2011) -
Be mindful of the central nervous system in Burkitt lymphoma
por: Roschewski, Mark
Publicado: (2021) -
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
por: Ayers, LW, et al.
Publicado: (2009) -
Nonlinear Burkitt lymphoma risk patterns with age and CD4 lymphocyte count among persons with AIDS in the United States
por: Guech-Ongey, Mercy, et al.
Publicado: (2010) -
Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma
por: Xian, Rena R., et al.
Publicado: (2021)